Thrita

Published by: Kowsar

Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients

Hamid Abousaeedi 1 , Omid Reza Hosseini 2 , * , Reza Bidaki 3 , Mahmood Sheikh Fathollahi 4 , Hamid Reza Goodarzi Nejad 5 , Golam Hossein Hassan Shahi 6 , Maryam Sahraei 7 , Shila Jalalpoor 8 and Mina Abousaiedi 9
Authors Information
1 Department of Infection Disease, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
2 Department of Infectious and Tropical Diseases, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, IR Iran
3 Research Center of Addiction and Behavioral Sciences, Shahid Sadoughi University of Medical Sciences, Yazd, IR Iran
4 Department of Social Medicine and Environment Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
5 Tehran Heart Center, Tehran University of Medical Sciences, Tehran, IR Iran
6 Department of Hematology, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
7 School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, IR Iran
8 Young Researchers Club, Shahreza Branch, Islamic Azad University, Shahreza, IR Iran
9 Department of Accounting, Kerman Branch, Islamic Azad University, Kerman, IR Iran
Article information
  • Thrita: December 2016, 5 (4); e36365
  • Published Online: March 27, 2016
  • Article Type: Research Article
  • Received: January 15, 2016
  • Revised: February 6, 2016
  • Accepted: February 29, 2016
  • DOI: 10.5812/thrita.36365

To Cite: Abousaeedi H, Reza Hosseini O, Bidaki R, Sheikh Fathollahi M, Goodarzi Nejad H R, et al. Viral and Psychiatric Disorders in Methadone Maintenance Therapy (MMT) Clients, Thrita. 2016 ;5(4):e36365. doi: 10.5812/thrita.36365.

Abstract
Copyright © 2016, Thrita. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Napier TC, Vocci FJ. Addiction to alcohol and drugs of abuse is a horrific tragedy for affected individuals and their families, and a financial, legal, and social burden for societies. Pharmacol Ther. 2005; 108(1): 1-2[DOI][PubMed]
  • 2. Rahimi-Movaghar A, Amin-Esmaeili M, Haghdoost AA, Sadeghirad B, Mohraz M. HIV prevalence amongst injecting drug users in Iran: a systematic review of studies conducted during the decade 1998-2007. Int J Drug Policy. 2012; 23(4): 271-8[DOI][PubMed]
  • 3. Perez Gonzalez K, Domingo-Salvany A, Hartnoll R. [Prevalence of human immunodeficiency virus and risk behaviours among opioid users seen in an emergency room]. Gac Sanit. 1999; 13(1): 7-15[PubMed]
  • 4. Des Jarlais DC, Friedman SR. HIV infection among intravenous drug users: epidemiology and risk reduction. AIDS. 1987; 1(2): 67-76[PubMed]
  • 5. Napoli C, Tafuri S, Pignataro N, Tedesco G, Maria AS, Quarto M. Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence. J Prev Med Hyg. 2010; 51(3): 101-4[PubMed]
  • 6. Caiaffa WT, Zocratto KF, Osimani ML, Martinez PL, Radulich G, Latorre L, et al. Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction. 2011; 106(1): 143-51[DOI][PubMed]
  • 7. McGovern MP, McLellan AT. The status of addiction treatment research with co-occurring substance use and psychiatric disorders. J Subst Abuse Treat. 2008; 34(1): 1-2[DOI][PubMed]
  • 8. Zamani S, Kihara M, Gouya MM, Vazirian M, Nassirimanesh B, Ono-Kihara M, et al. High prevalence of HIV infection associated with incarceration among community-based injecting drug users in Tehran, Iran. J Acquir Immune Defic Syndr. 2006; 42(3): 342-6[DOI][PubMed]
  • 9. Shekarchizadeh H, Ekhtiari H, Khami MR, Virtanen JI. Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran. Harm Reduct J. 2012; 9: 18[DOI][PubMed]
  • 10. Moolchan ET, Umbricht A, Epstein D. Therapeutic drug monitoring in methadone maintenance: choosing a matrix. J Addict Dis. 2001; 20(2): 55-73[DOI][PubMed]
  • 11. Esteban J, de la Cruz Pellin M, Gimeno C, Barril J, Mora E, Gimenez J, et al. Detection of clinical interactions between methadone and anti-retroviral compounds using an enantioselective capillary electrophoresis for methadone analysis. Toxicol Lett. 2004; 151(1): 243-9[DOI][PubMed]
  • 12. Verster A, Buning E. Methadone guidelines. 2000;
  • 13. Golden J, O'Dwyer AM, Conroy RM. Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors. Gen Hosp Psychiatry. 2005; 27(6): 431-8[DOI][PubMed]
  • 14. Alavian SM, Tavallaei SA, Hoseini SM, Hedayati MR, Sepehrinia A. Prevalence of Depression in Chronic Hepatitis B and C Patients Treated with ‎Interferon. Trauma Mon. 2007; 12(2): 161-7
  • 15. Alavian SM. Hepatitis C infection in Iran; A review article. Arch Clin Infec Dis. 2009; 4(1): 47-59
  • 16. Haghdoost AA, Mostafavi E, Mirzazadeh A, Navadeh S, Feizzadeh A, Fahimfar N, et al. Modelling of HIV/AIDS in Iran up to 2014. J AIDS HIV Res. 2011; 3(12): 231-9[DOI]
  • 17. Parvaresh N, Masoudi A, Majidi-Tabrizi S, Mazhari S. The Correlation between Methadone Dosage and Comorbid Psychiatric Disorders in Patients on Methadone Maintenance Treatment. Addict Health. 2012; 4(1-2): 1-8[PubMed]
  • 18. Shirazi KK, Heydarnia E, Kamalianfard S, Heydarnia M, Fararooie M, Rahimi E. P01-104-Exploring the mental status of people with opium and heroin addiction. European Psychiatr. 2011; 26(1): 104
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments